Skip to main content
Clinical Trials/CTRI/2023/02/049710
CTRI/2023/02/049710
Not yet recruiting
Phase 4

Comparative evaluation of Dexmedetomidine versus Dexamethasone as adjuvant to ropivacaine 0.5% in ultrasound guided single shot costotransverse block for analgesia in unilateral breast surgeries: A Randomized Clinical Trial

Department of Anaesthesia and Intensive care0 sites0 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
Department of Anaesthesia and Intensive care
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
Department of Anaesthesia and Intensive care

Eligibility Criteria

Inclusion Criteria

  • American Society of Anesthesiologists (ASA) class I\-II
  • Age more than 18 years at the date of inclusion
  • Females posted for breast surgery
  • Who have received thorough information and have signed the informed written consent form

Exclusion Criteria

  • Patient refusal ASA III\- IV including patient with severe respiratory, cardiovascular, liver and metabolic or pre\-existing neurological deficit Skin infection at puncture site Allergy to study drugs
  • Recent history of use of analgesic/steroid drugs Pregnant patient
  • History of psychiatric illness and substance abuse.
  • Morbid obesity BMI \>\=40 kg/m2 Coagulation abnormalities (INR \>1\.5, thrombocytopenia)

Outcomes

Primary Outcomes

Not specified

Similar Trials